Bio-FD&C Co

Bio-FD&C Co Accounts Payable

The Accounts Payable of Bio-FD&C Co (251120.KQ) as of Nov 14, 2026 is 109.69 M KRW. In the previous year, Accounts Payable was 125.59 M KRW — a change of -12.66% (lower).

Accounts Payable

109.69 MKRW

YoY

-12.66%

Last updated:

Accounts Payable of Bio-FD&C Co is 2025 109.69 M KRW. Accounts Payable of Bio-FD&C Co was 2024 125.59 M KRW. It decreases by -12.66% lower compared to the previous year.

The Bio-FD&C Co Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2020
12.77 M KRW
Jan 1, 2021
1.22 B KRW
Jan 1, 2022
64.16 M KRW
Jan 1, 2023
130.90 M KRW
Jan 1, 2024
125.59 M KRW
Jan 1, 2025
109.69 M KRW
The Bio-FD&C Co Accounts Payable history
YEARAccounts PayableYoY
109.69 MKRW-12.66%
125.59 MKRW-4.06%
130.90 MKRW+104.02%
64.16 MKRW-94.73%
1.22 BKRW+9,424.71%
12.77 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Accounts Payable of Bio-FD&C Co is 109.69 M KRW in 2025.

Accounts Payable of Bio-FD&C Co changed from 125.59 M KRW to 109.69 M KRW, representing a -12.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Bio-FD&C Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Bio-FD&C Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bio-FD&C Co